{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:21:04Z","timestamp":1784042464229,"version":"3.55.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec008\">\n<jats:title>Background<\/jats:title>\n<jats:p>Myasthenia gravis is an autoimmune disorder that affects the neuromuscular junction resulting in muscle weakness and fatigue. The aim of this study was to investigate the indications for and frequency of intensive care unit admissions in people with myasthenia gravis in addition to exploring the clinical presentations and outcomes during their admission.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec009\">\n<jats:title>Methods and Findings<\/jats:title>\n<jats:p>This retrospective study included all adult patients diagnosed with myasthenia gravis who were admitted to the intensive care unit in a six year period. Twenty-four patients with a diagnosis of myasthenia gravis were included in this study, with a total of 60 admissions. The median age at their first admission was 45 years with female predominance. Majority of the patients (87.5%) were acetylcholine antibody positive and 66.7% of patients had thymectomy. Myasthenic crisis was the most common reason for intensive care unit admission (63.3%). 80.5% of patients admitted with myasthenic crisis were treated with plasma exchange. During their admission, 45% of patients required mechanical ventilation. Complications during hospitalization were reported in 18.3% of patients, with mortality rate of 5% of all admissions.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec010\">\n<jats:title>Conslusion<\/jats:title>\n<jats:p>People with myasthenia gravis are commonly admitted to the intensive care unit due to myasthenic crises, however, there were minimal complications reported and a low mortality rate.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0328648","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T17:37:58Z","timestamp":1753724278000},"page":"e0328648","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Outcomes of myasthenia gravis patients admitted to the Intensive Care Unit: Experience from a tertiary care center in Saudi Arabia"],"prefix":"10.1371","volume":"20","author":[{"given":"Ahmed","family":"Attar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatoon","family":"Alshaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2003-4004","authenticated-orcid":true,"given":"Ghadi","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tala","family":"Aletani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9931-647X","authenticated-orcid":true,"given":"Sarah","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0173-6701","authenticated-orcid":true,"given":"Osama","family":"Khojah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahma","family":"Alqthmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Althobaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thamer","family":"Alaifan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"issue":"8","key":"pone.0328648.ref001","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1212\/01.wnl.0000254620.45529.97","article-title":"Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis","volume":"68","author":"F Deymeer","year":"2007","journal-title":"Neurology"},{"issue":"12","key":"pone.0328648.ref002","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.1007\/s10072-022-06379-z","article-title":"Myasthenia gravis treated in the neurology intensive care unit: a 14-year single-centre experience","volume":"43","author":"M Zdraljevic","year":"2022","journal-title":"Neurol Sci"},{"issue":"2","key":"pone.0328648.ref003","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis","volume":"37","author":"D Grob","year":"2008","journal-title":"Muscle Nerve"},{"issue":"1","key":"pone.0328648.ref004","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mus.27832","article-title":"Myasthenic crisis","volume":"68","author":"B Claytor","year":"2023","journal-title":"Muscle Nerve"},{"issue":"18","key":"pone.0328648.ref005","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1212\/WNL.0b013e3181a41211","article-title":"Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals","volume":"72","author":"A Alshekhlee","year":"2009","journal-title":"Neurology"},{"issue":"5","key":"pone.0328648.ref006","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.48.5.1253","article-title":"Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation","volume":"48","author":"CE Thomas","year":"1997","journal-title":"Neurology"},{"key":"pone.0328648.ref007","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jcrc.2018.01.003","article-title":"Characteristics, incidence, and outcome of patients admitted to the intensive care unit with myasthenia gravis","volume":"45","author":"W Al-Bassam","year":"2018","journal-title":"J Crit Care"},{"issue":"4","key":"pone.0328648.ref008","doi-asserted-by":"crossref","first-page":"237","DOI":"10.17712\/nsj.2022.4.20220038","article-title":"Outcomes and characteristics of myasthenia gravis: A 10-year retrospective cross-sectional study at King Fahad Medical City","volume":"27","author":"A Ali","year":"2022","journal-title":"Neurosciences (Riyadh)"},{"key":"pone.0328648.ref009","doi-asserted-by":"crossref","first-page":"116830","DOI":"10.1016\/j.jns.2020.116830","article-title":"Exploring outcomes and characteristics of myasthenia gravis: Rationale, aims and design of registry - The EXPLORE-MG registry","volume":"414","author":"R Anil","year":"2020","journal-title":"J Neurol Sci"},{"key":"pone.0328648.ref010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in Myasthenia Gravis","volume":"10","author":"AS Carr","year":"2010","journal-title":"BMC Neurol"},{"issue":"5","key":"pone.0328648.ref011","doi-asserted-by":"crossref","first-page":"341","DOI":"10.5144\/0256-4947.2008.341","article-title":"Myasthenia gravis: presentation and outcome in 104 patients managed in a single institution","volume":"28","author":"MA Al-Moallem","year":"2008","journal-title":"Ann Saudi Med"},{"issue":"12","key":"pone.0328648.ref012","article-title":"Clinical Presentation, Management, and Outcome in Patients With Myasthenia Gravis: A Retrospective Study From Two Tertiary Care Centers in Saudi Arabia","volume":"13","author":"H Algahtani","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"pone.0328648.ref013","doi-asserted-by":"crossref","first-page":"7","DOI":"10.25122\/jml-2020-0145","article-title":"The epidemiology of myasthenia gravis","volume":"14","author":"A-M Bubuioc","year":"2021","journal-title":"J Med Life"},{"issue":"2","key":"pone.0328648.ref014","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1468-1331.1998.520137.x","article-title":"The management and outcome of patients with myasthenia gravis treated acutely in a neurological intensive care unit","volume":"5","author":"JI O\u2019Riordan","year":"1998","journal-title":"Euro J of Neurology"},{"issue":"2","key":"pone.0328648.ref015","article-title":"Clinical features and outcomes of patients with myasthenia gravis admitted to an intensive care unit: A 20-year retrospective study","volume":"39","author":"GEMP 2 Group 6 of 2018","year":"2023","journal-title":"South Afr J Crit Care"},{"issue":"3","key":"pone.0328648.ref016","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000008688","article-title":"Myasthenic crisis demanding mechanical ventilation: A multicenter analysis of 250 cases","volume":"94","author":"B Neumann","year":"2020","journal-title":"Neurology"},{"issue":"2","key":"pone.0328648.ref017","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3988\/jcn.2009.5.2.53","article-title":"Muscle-specific receptor tyrosine kinase antibody positive myasthenia gravis current status","volume":"5","author":"SJ Oh","year":"2009","journal-title":"J Clin Neurol"},{"key":"pone.0328648.ref018","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3389\/fneur.2020.00660","article-title":"MuSK-Associated Myasthenia Gravis: Clinical Features and Management","volume":"11","author":"C Rodolico","year":"2020","journal-title":"Front Neurol"},{"issue":"7","key":"pone.0328648.ref019","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/ene.12703","article-title":"Myasthenia gravis: descriptive analysis of life-threatening events in a recent nationwide registry","volume":"22","author":"A Ramos-Fransi","year":"2015","journal-title":"Eur J Neurol"},{"issue":"6","key":"pone.0328648.ref020","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/mus.26689","article-title":"Factors associated with acute exacerbations of myasthenia gravis","volume":"60","author":"RR Gummi","year":"2019","journal-title":"Muscle and Nerve"},{"key":"pone.0328648.ref021","doi-asserted-by":"crossref","first-page":"733418","DOI":"10.3389\/fimmu.2021.733418","article-title":"To Be or Not To Be Vaccinated: That Is a Question in Myasthenia Gravis","volume":"12","author":"Q Zhou","year":"2021","journal-title":"Front Immunol"},{"key":"pone.0328648.ref022","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3109\/08916930903518107","article-title":"Immunosuppressive therapies in myasthenia gravis","volume":"43","author":"DB Sanders","year":"2010","journal-title":"Autoimmunity"},{"issue":"4","key":"pone.0328648.ref023","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: Executive summary","volume":"87","author":"DB Sanders","year":"2016","journal-title":"Neurology"},{"key":"pone.0328648.ref024","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3389\/fneur.2020.00604","article-title":"A Practical Approach to Managing Patients With Myasthenia Gravis-Opinions and a Review of the Literature","volume":"11","author":"ME Farrugia","year":"2020","journal-title":"Front Neurol"},{"issue":"3","key":"pone.0328648.ref025","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","article-title":"International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update","volume":"96","author":"P Narayanaswami","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"pone.0328648.ref026","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12028-008-9139-y","article-title":"The role of non-invasive ventilation and factors predicting extubation outcome in myasthenic crisis","volume":"10","author":"J-Y Wu","year":"2009","journal-title":"Neurocrit Care"},{"issue":"12","key":"pone.0328648.ref027","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.nmd.2021.08.008","article-title":"Predictors of outcome in patients with myasthenic crisis undergoing non-invasive mechanical ventilation: A retrospective 20 year longitudinal cohort study from a single Italian center","volume":"31","author":"E Iori","year":"2021","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"pone.0328648.ref028","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12883-019-1384-5","article-title":"Myasthenic crisis treated in a Chinese neurological intensive care unit: clinical features, mortality, outcomes, and predictors of survival","volume":"19","author":"F Liu","year":"2019","journal-title":"BMC Neurol"},{"issue":"8","key":"pone.0328648.ref029","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00134-013-2960-6","article-title":"The effect of secular trends and specialist neurocritical care on mortality for patients with intracerebral haemorrhage, myasthenia gravis and Guillain-Barr\u00e9 syndrome admitted to critical care\u00a0: an analysis of the Intensive Care National Audit & Research Centre (ICNARC) national United Kingdom database","volume":"39","author":"MS Damian","year":"2013","journal-title":"Intensive Care Med"},{"issue":"1","key":"pone.0328648.ref030","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s12883-021-02412-4","article-title":"Hemogram parameters can predict in-hospital mortality of patients with Myasthenic crisis","volume":"21","author":"C-W Hsu","year":"2021","journal-title":"BMC Neurol"},{"issue":"4","key":"pone.0328648.ref031","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/ene.14153","article-title":"Serious infections in patients with myasthenia gravis: population\u2010based cohort study","volume":"27","author":"CD Kassardjian","year":"2020","journal-title":"Euro J of Neurology"},{"issue":"7","key":"pone.0328648.ref032","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1007\/s00415-023-11733-y","article-title":"Myasthenia gravis, respiratory function, and respiratory tract disease","volume":"270","author":"NE Gilhus","year":"2023","journal-title":"J Neurol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0328648","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T17:38:02Z","timestamp":1753724282000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0328648"}},"subtitle":[],"editor":[{"given":"Mainak","family":"Bardhan,","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":32,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0328648","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]}}}